Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and safety of nitazoxanide
compared to a placebo in reducing the signs and symptoms of mild to moderate active Crohn's
disease in adults.